News & Press Releases

The Journal of Pension Benefits published an article written by Of Counsel Michelle Capezza about 401(k) retirement plans and the need to assist plan participants in managing their retirement assets in the decumulation phase. Michelle writes that plan sponsors should consider how to improve their retirement programs to address this need.

Mintz advised Altamira Technologies Corporation, an open-source technology company in the national security space, on its acquisition by Parsons Corporation, a leading national security and global infrastructure technology provider. The transaction is valued at $375 million, including $330 million in cash at closing and an additional $45 million earn-out contingent on 2026 EBITDA targets.

Mintz advised the placement agents in connection with a $1 billion registered direct offering of 19,000,000 shares of common stock and, in lieu of common stock, pre-funded warrants to purchase up to 41,790,274 shares of common stock. Each share of common stock and each pre-funded warrant was sold with a common stock warrant to purchase two shares of common stock. 

Mintz advised the underwriters in connection with a $661 million public offering by Praxis Precision Medicines of 2,543,800 shares of common stock (which includes 331,800 shares of common stock issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock) at a public offering price of $260.00 per share.

Mintz advised User Interviews, the leading participant recruitment platform for user and market research and AI training, on its sale to UserTesting, the leading provider of customer insights for enterprise-scale companies. UserTesting was acquired by funds affiliated with Thoma Bravo and Sunstone Partners in 2022.

Member Ken Jenkins was quoted in an article by UCSF Innovation Ventures focused on an FDA approved autoimmune drug, Rilzabrutinib, which went from a university invention to a marketable drug.